HPS Home Power Solutions GmbH announces first closing of its financing round at € 7.5 million

Ergomed plc: Board and Management Changes

Abivax Hosts KOL Event in Geneva on Therapeutic Candidate ABX464 for Ulcerative Colitis

nova funds: Gesundheitsaktienfonds nova Steady HealthCare erzielt 2018 erneut sehr gutes Ergebnis

Medigene AG: Medigene participates at four upcoming conferences

Allergy Therapeutics announces business development ppdate and publication date of half year results for FY 2018/2019

Newron Pharmaceuticals: Commercialization partner Zambon together with Valeo Pharma announce the approval of Onstryv® (safinamide) for Parkinson’s disease in Canada

Adocia confirms its financial calendar for 2019

Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance

Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554